HR-POSITIVE BREAST CANCER

Clinical trials for HR-POSITIVE BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new HR-POSITIVE BREAST CANCER trials appear

Sign up with your email to follow new studies for HR-POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug trial aims to extend treatment time and quality of life for advanced breast cancer

Disease control Recruiting now

This study is testing if adding the drug capivasertib to standard hormone therapy can help people with a specific type of advanced breast cancer stay on their treatment longer and maintain their quality of life. It is for adults whose cancer has continued to grow despite prior ho…

Matched conditions: HR-POSITIVE BREAST CANCER

Phase: PHASE3 • Sponsor: West German Study Group • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

HR-POSITIVE BREAST CANCER

Get alerted when new HR-POSITIVE BREAST CANCER trials appear

New drug trial aims to extend treatment time and quality of life for advanced breast cancer